White paper: Tips for tailoring eConsent for optimal patient centricity

    Oct. 12, 2022
    Pharma Manufacturing Medable Pca

    Over 70% of potential research participants live >2 hours away from sites, & patient drop-out rates can reach 30% depending on the therapeutic area.

    The Solution: eConsent

    Why?

    1. Medable eConsent enables the enrollment of underrepresented, diverse populations through remote consenting.
    2. Medable eConsent has proven to reduce screening timelines by 50%, & increase patient engagement by 15%+.

    This white paper is sponsored by Medable .

    A valid email address is required to receive a copy of this PDF.

    Continue Reading